IP78-27: Differential Effects of First-Line IO–TKI and IO–IO Therapy on Muscle and Fat Loss in Metastatic Renal Cell Carcinoma
Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!